ELCC 2019: European Lung Cancer Congress

Maintenance immunotherapy did not improve survival in patients with extensive-stage small cell lung cancer (SCLC), according to late-breaking results from the CheckMate 451 study presented today by Ow...

lung cancer

issues in oncology

immunotherapy

By The ASCO Post Staff / ELCC 2019: European Lung Cancer Congress

ELCC 2019: Immunotherapy in Elderly Patients With Advanced NSCLC

Two studies reported at the European Lung Cancer Congress (ELCC) 2019 provided new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non–small cell lung...

ELCC 2019: European Lung Cancer Congress

ELCC 2019: Does Maintenance Immunotherapy Improve Survival in Patients With Advanced SCLC?

ELCC 2019: Immunotherapy in Elderly Patients With Advanced NSCLC

FDA Approves Datopotamab Deruxtecan-dlnk for Advanced HR-Positive, HER2-Negative Breast Cancer

FDA Approves Sotorasib With Panitumumab for KRAS G12C–Mutated Colorectal Cancer

Fulvestrant vs Anastrozole in Endocrine Therapy–Naive, HR-Positive, HER2-Negative Advanced Breast Cancer

AACR Expresses Sincere Appreciation After NIH Director Monica M Bertagnolli MD Steps Down

FDA Approves Acalabrutinib With Bendamustine and Rituximab for Previously Untreated Mantle Cell Lymphoma